I suppose one needs to accept that pro was sort of correct here. I exited some time ago, which I posted here, at a happy profit, though not as much as I had hoped. But the poor sales numbers sent me away. Anyhow, I say congrats to the pro, though it didn't get down to the 6 or so you predicted, I think. Not clear if you make money here or not but you were more or less correct in concept.
thx, appreciate the credit, at least one prior Long on this board is man enough to give it. Yes, I was off a few bucks, however, I still think the valuation is crazy expensive and will wait for the buy out price to cover. I was on point on most other topics regarding OPTR and it's dog FIDO....Longs should consider themselves lucky and get out at these prices!!
unfortunately, the arguments from pro were never about patient care - i.e., if docs prescribed the best for their patients, I believe they would prescribe fido; unfortunately, it has not been adopted as fast I had hoped, mainly because many physicians (and insurance companies) apparently hold the same belief that cost should dictate prescriptions...if I am the patient, I disagree wholeheartedly. I, too, got out a looong time ago, but never respected pro's arguments that vanco will always be the best answer for c-diff...seen too many bad cases to belief you should treat it with anything but the most effective product on the market. sure, he might make a few bucks, but so did I.